Kevin M. Lalande, Director at LUMOS PHARMA, INC. (LUMO), bought 20,000 shares at $11.21 ($224K) on 2021-09-08, disclosed to the SEC on 2021-09-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.21 | 10,000 | $112K | 50.0% |
| 2 | $11.21 | 10,000 | $112K | 50.0% |
| Total | $11.21 avg | 20,000 | $224K | 100% |
| Filing → |
| LUMO | BUY | 2021-09-01 | $269K | — | Filing → |
| LUMO | BUY | 2021-08-27 | $314K | — | Filing → |
| LUMO | BUY | 2021-08-24 | $1.2M | — | Filing → |